Background: The reactive oxygen species lead to skin aging via oxidative damage
defense mechanisms. Enzymes and antioxidant substances react directly with reactive oxygen species and preventing them from reaching their biological target. 4, 5 UV radiation is an external factor which influences the photoaging. It can be prevented by various antioxidants in a variety of skincare products.
In this study, astaxanthin (3,3 P-dihydroxyl-4,4P-dioxo-L-carotene) was chosen as an effective antioxidant agent. It is a common lipophilic pigment found in algae, fish, and birds. 6, 7 It is more efficient than many antioxidant agents such as carotenoid and vitamin E. Due to antioxidant effect, it could be used as anti-aging agent caused by UV radiation. Although there are few studies that mentioned topical preparation of astaxanthin, [8] [9] [10] [11] there is no any commercial product.
Gel formulations have many advantages such as low cost and ease of use, production and scale-up. In this study, astaxanthincontaining oleoresin and algae extract were used as antioxidant materials to prepare hydrogel and lipogel formulations as anti-aging products. Gel formulations containing astaxanthin were characterized via parameters, pH, rheological and mechanical properties, and stability. In vitro release experiments of the formulations, antioxidant activity assay for the determination of efficiency and cell culture studies for cytotoxicity test were performed.
| MATERIALS AND METHODS

| Materials
Astaxanthin oleoresin (5%) and astaxanthin-containing algae extract were purchased from Tab drug company (Istanbul, Turkey) and University of Mustafa Kemal (Hatay, Turkey), respectively. Lecithin, isopropyl myristate, and propylene glycol were purchased from AppliChem (Istanbul, Turkey). Carbopol 974P were purchased from Lubrizol. All other chemicals and reagents used in this study were of analytical grade or higher, obtained commercially.
| Preparation of gel formulations
Lipogel and hydrogel formulations were prepared with two different origins of astaxanthin. Firstly, formulations were prepared with astaxanthin oleoresin (5%) (AO) and then with astaxanthin algae extract (0.8%) (AE).
Lipogel formulations were prepared by dissolving egg lecithin in the mixture of isopropyl myristate, propylene glycol, and ethanol.
Then, astaxanthin oleoresin or astaxanthin algae extract was added to mixture (phase A). Carbopol was mixed with distilled water and kept at room temperature over the night for swelling. Triethanolamine was added for neutralization and gelling of polymer (phase B). Finally, astaxanthin mixture (phase A) was added to carbopol gel system (phase B) to obtain astaxanthin lipogel formulations (AO-L and AE-L).
Carbopol 974P gel systems were used to obtain hydrogel formulations of astaxanthin. Hydrogel systems were prepared as mentioned above (phase B). Astaxanthin oleoresin (AO-H) and astaxanthin algae extract (AE-H) were added to gels and mixed by magnetic stirrer. The astaxanthin concentration of all formulations was 500 lg/g (Table 1 ).
| Characterization of formulations
The macroscopical analysis of formulations was performed via controlling appearance, phase separation, and color of formulations.
The pH values of the formulations were determined using a pH meter (Jenway 3040 Ion Analyze) at 25 AE 1°C. All experiments were replicated at least three times.
The rheological analysis of the formulations was performed at 32 AE 0.1°C and at 25 AE 0.1°C using an AR 2000 controlled stress/ controlled rate rheometer (Haake MARS, Platte PP35 Ti, plate cover MPC35, Karlsruhe, Germany). In continuous shear analysis, the upward and downward flow curves for each formulation were measured over shear rates ranging from 10 to 900 s-1. 12,13 All experiments were replicated at least five times.
Oscillatory analysis of each formulation was performed at 25 AE 0.1°C and 32 AE 0.1°C, where stress was directly proportional to strain and the storage modulus remained constant. Frequency sweep analysis was carried out over the frequency range of 0.1-10.0 Hz following application of a constant stress. Storage modulus (G 0 ) and loss modulus (G″), the dynamic viscosity (ή 0 ), and the loss tangent (tan d) were determined as previously described by the authors. 14, 15 The mechanical behavior of the formulations was measured using a TA-XT Plus Texture Analyzer (Stable Micro Systems UK) equipped with 5-kg load cell in texture profile analysis (TPA) mode. From the resultant force-time curve, the mechanical parameters (hardness, compressibility, adhesiveness, and cohesiveness) were determined. 16 Experiments were carried out at least five times, and standard deviations were calculated.
The stability of formulations was studied for 3 months by the means of drug content, pH, and viscosity. The formulations were 2.6 | Solubility study of astaxanthin algae extract 
| In vitro drug release
The concentration of astaxanthin in the gels was determined before starting in vitro release studies. The certain amount of gel formulations was dissolved with DMSO and mixed with vortex for 15 minutes. After filtration, the active agent concentrations were found.
The study was performed with formulations without drug to show specificity of analytical method.
The dialysis bag diffusion technique was used to study the in vitro drug release of astaxanthin. 1 g of lipogel and hydrogel of formulations was placed in the dialysis bag (cellulose membrane, molecular weight cutoff 12-14 000 D), hermetically sealed, and immersed into 100 mL of PBS (pH 7.4): ethanol (7:3, v/v) mixture.
The entire system was kept at 37 AE 0.5°C with continuous magnetic stirring at 600 rpm/min. Samples were withdrawn from the receptor compartment at predetermined time intervals and replaced by fresh medium. The amount of drug released was determined by HPLC.
| Cell culture studies
Cytotoxicity potential of the formulations was evaluated by MTT (3-
MTT reagent is a yellow substrate which produces a dark blue (A b is the absorbance of the blank, and A a is the absorbance of the sample). 
The standard curve of the Trolox was obtained using a Trolox 
| The limitations of the study
The study has some limitations. Firstly, the in vivo studies could not perform because the ethic committee does not allow animal use for cosmetic products. Secondly, the ex vivo studies were not performed, because the prepared formulations would be used topically.
The authors do not expect any systemic effect.
| Statistical analysis
Data were expressed as mean AE standard deviations (mean AE SD).
Differences among the groups were analyzed using one-way ANOVA followed, where appropriate, by Tukey's post hoc test. Statistical analysis was performed using GraphPad Prism 5.0 (GraphPad Software). For all comparisons, a value of P < .05 was considered significant. Results were derived from three independent experiments.
3 | RESULTS AND DISCUSSION
| Characterization of formulations
Oleoresin formulations had purple color, and algae extract formulations had red color. Lipogel formulations had less viscosity than hydrogel due to lower concentration of polymer. The pH of formulations was range from 4.5 to 5. The pH values are suitable for topical application as the skin pH is 5.5. 22 The results of macroscopic observation and pH are shown in Table 2 .
The rheological properties of gel systems affect both the ease of application and spreadability on skin. Representative flow curves were graphically presented in Figure 1 . The shear stress changes upon shear rates have been used to determine whether the rheological behavior of the formulation is Newtonian or non-Newtonian. The shear stress is increasing with increasing shear rate. The flow is not starting from origin point, and this showed the formulations exhibited plastic flow at 25°C and at 32°C. As shown in Figure 1 , viscosity decreases with increasing shear rate, as expected from plastic fluids. The lipogel formulations showed lower viscosity than hydrogels. Lipogel formulations which were prepared with oleoresin astaxanthin had higher viscosity than algae extract astaxanthin due to viscosity of resin.
The oscillatory stresses on the viscoelastic properties are measured from two dynamic moduli: One is the storage modulus, G 0 , and other is the loss modulus, G″. G 0 measures the elasticity of system, and G″ represents viscous components. A gel system exhibits a solid-like mechanical spectrum, that is, G 0 > G″. 15 Tables 3 and 4 represent the frequency dependence of the G″ and G 0 of gel formulations at 25°C and 32°C. As shown, all formulations found were nearly frequency independent after certain frequency values and they exhibited typical gel-type mechanical spectra
. AO-L and AO-K formulations could be described as strong cross-linked gel, and they did not influence by the frequency of oscillation.
The value of the loss tangent (tan d = G″/G 0 ) is a measure of the relative contribution of viscous components to the mechanical properties of the materials. For solid systems, it should be <1, and for liquid systems, it should be >1. 23 For all gel formulations, the loss tangent was found <1 for both degrees ( Table 5 ).
The textural properties of gels were performed to assess the applicability of gels to skin (Table 6) . Mechanical parameters such as hardness, compressibility, adhesiveness, cohesiveness, and elasticity were defined from the resultant force-time curve. 12 The gel systems could be easily removed from container and spread on skin surface when the gel hardness and compressibility are low. 15 Cohesiveness and adhesiveness are important parameters for the structural properties of formulations. A lower value of elasticity indicates higher product elasticity, and this shows product could be easily transformed from deformed to undeformed conditions. The results show that carbopol affects the structural properties of formulations. Formulations jellified with carbopol had similar hardness and other textural values. Lipogel prepared with algae extract had lowest values.
On the other hand, oleoresin lipogel showed higher textural values than lipogel prepared with algae extract due to mechanical properties of oleoresin.
The result of stability studies showed that the formulations were stable during 3 months under mentioned conditions. The pH and viscosity of formulations did not change after 3 months. indicates the percentage of drug content in the formulations. As shown, a slight change was observed for both of the conditions (P > .05).
| Analytical method for determination of astaxanthin
A validated HPLC method was developed to determine the astaxanthin in samples. The variation coefficient of accuracy, precision, and solution stability found was lesser than two percent, indicating the method was validated. The specificity of method was proved by injecting the formulations without drug to HPLC system. The limit of detection (LOD) and limit of quantification (LOQ) were also determined, and the results found were 3.3x10-4 lg/mL and 10-3 lg/m, respectively.
| Determination of astaxanthin in algae extract
The drug concentration of algae extract was not known. The amount of drug in oleoresin was determined by company. The drug content in algae extract was determined by the use of oleoresin as standard. And it was found that the astaxanthin concentration in extract is 0.8%. parisons, a value of P < .05 was considered significant. Results were derived from three independent experiments. Figure 3 shows the results for control group and formulation. In previous studies, no negative effect was observed in terms of cell proliferation and viability (P > .05). Moreover, it was determined that AO and AE induced HK-2 cell proliferation in a dose-dependent manner.
The results of MTT assay showed that any of formulation had cytotoxic effects. Moreover, it was observed that AO and AO-L formulations caused a significant increase in cell proliferation compared to untreated and only vehicle-treated cells (P < .01), whereas there was no significant increase in AO-K formulation-treated cell (P > .05).
Similarly, it was determined that AE and AE-L caused a significant improvement in cell proliferation in a dose-dependent manner compared to untreated and only vehicle-treated cells (P < .05). On the other hand, there was no significant increase in AE-K formulation-treated cell (P > .05).
In previous studies, it has been demonstrated that astaxanthin improved epithelial cell proliferation due to antioxidant-dependent activity. 24 Our findings indicated that astaxanthin also induced HK-2 cell proliferation in a dose-dependent manner. In addition, astaxanthin is more proliferative in lipogel formulation compared to hydrogel formulations.
| Antioxidant activity studies
The antioxidant activities of astaxanthin-containing hydrogel and lipogel formulations were conducted for two different radicals: dose-dependent manner (P < .05). In addition, it was observed that AE showed significantly higher DPPH scavenging activity in K compared to L at 0.5 mg/mL concentration (P < .05) while AO showed higher scavenging activity in L compared to K formulation (P < .05). astaxanthin. Similar to DPPH scavenging activity results, the highest antioxidant activity was determined for an addition of 0.5 mg/mL astaxanthin into AE-K and AE-L formulation (P < .05).
Moreover, it was determined that L formulation of AO and AE was showed significantly higher antioxidant activity compared to K at 0.5 mg/mL concentration (P < .05).
However, it has been reported that astaxanthin is more effective than carotenoid and vitamin E, and there is a limited number of studies showing the antioxidant activity of astaxanthin in topical formulations. 10, 11 In this study, our results clearly indicate that the astaxanthin shows strong antioxidant activity in both lipogel and hydrogel formulations. These findings support previous studies about the antioxidant effects of astaxanthin in topical formulations. [8] [9] [10] [11] In addition, both DPPH and TEAC assays have shown that AE-containing formulations exhibit more effective antioxidant properties than 
| CONCLUSION
In this study, astaxanthin hydrogels and lipogels were prepared successfully for anti-aging. Astaxanthin algae extract lipogel formulation could be promising systems for topical application due to fast release profile and easier application. As a conclusion, an innovative topical formulation providing anti-aging efficacy, containing astaxanthin that had a strong antioxidant activity, was developed. 
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